Nucleic Acids Research, 2003, Vol. 31, No. 7 1904-1912
© 2003 Oxford University Press
Pathology-related substitutions in human mitochondrial tRNAIle reduce precursor 3' end processing efficiency in vitro
1 UPR 9002 de CNRS, IBMC 15 rue René Descartes, 67084 Strasbourg Cedex, France and 2 York College/CUNY, 94-20 Guy R. Brewer Boulevard, Jamaica, NY 11451, USA
*To whom correspondence should be addressed at York College/CUNY, 94-20 Guy R. Brewer Boulevard, Jamaica, NY 11451, USA. Tel: +1 718 262 2704; Fax: +1 718 262 2652; Email: louie{at}york.cuny.edu
The human mitochondrial genome encodes 22 tRNAs interspersed among the two rRNAs and 11 mRNAs, often without spacers, suggesting that tRNAs must be efficiently excised. Numerous maternally transmitted diseases and syndromes arise from mutations in mitochondrial tRNAs, likely due to defect(s) in tRNA metabolism. We have systematically explored the effect of pathogenic mutations on tRNAIle precursor 3' end maturation in vitro by 3'-tRNase. Strikingly, four pathogenic tRNAIle mutations reduce 3'-tRNase processing efficiency (Vmax / KM) to
10-fold below that of wild-type, principally due to lower Vmax. The structural impact of mutations was sought by secondary structure probing and wild-type tRNAIle precursor was found to fold into a canonical cloverleaf. Among the mutant tRNAIle precursors with the greatest 3' end processing deficiencies, only G4309A displays a secondary structure substantially different from wild-type, with changes in the T domain proximal to the substitution. Reduced efficiency of tRNAIle precursor 3' end processing, in one case associated with structural perturbations, could thus contribute to human mitochondrial diseases caused by mutant tRNAs.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Ling, H. Roy, D. Qin, M. A. T. Rubio, J. D. Alfonzo, K. Fredrick, and M. Ibba Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome PNAS, September 25, 2007; 104(39): 15299 - 15304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Scherer, R. Frank, and J. J. Rossi Optimization and characterization of tRNA-shRNA expression constructs Nucleic Acids Res., April 10, 2007; (2007) gkm103v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yan, N. Zareen, and L. Levinger Naturally Occurring Mutations in Human Mitochondrial Pre-tRNASer(UCN) Can Affect the Transfer Ribonuclease Z Cleavage Site, Processing Kinetics, and Substrate Secondary Structure J. Biol. Chem., February 17, 2006; 281(7): 3926 - 3935. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levinger, M. Morl, and C. Florentz Mitochondrial tRNA 3' end metabolism and human disease Nucleic Acids Res., October 11, 2004; 32(18): 5430 - 5441. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hino, T. Suzuki, T. Yasukawa, K. Seio, K. Watanabe, and T. Ueda The pathogenic A4269G mutation in human mitochondrial tRNAIle alters the T-stem structure and decreases the binding affinity for elongation factor Tu Genes Cells, March 1, 2004; 9(3): 243 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Dubrovsky, V. A. Dubrovskaya, L. Levinger, S. Schiffer, and A. Marchfelder Drosophila RNase Z processes mitochondrial and nuclear pre-tRNA 3' ends in vivo Nucleic Acids Res., January 9, 2004; 32(1): 255 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Jacobs Disorders of mitochondrial protein synthesis Hum. Mol. Genet., October 15, 2003; 12(90002): R293 - 301. [Abstract] [Full Text] [PDF] |
||||




